To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open179.45
High182.8
Low178
Prev. Close178.52
Avg. Traded Price180.04
Volume1,36,240

MARKET DEPTH

info2
Total bid1.00
Total ask0.00
OrdersQtyBid
11178.52
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

178.00an hour ago
182.807 hours ago
arrow

LOWER/UPPER CIRCUITS

173.67
191.96
arrow
Standard Glass Lining Technology Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 13.88%, in the last year to ₹625.97 Cr. Its sector's average revenue growth for the last fiscal year was 12.07%.
noteAnnual Net Profit,rose 10.21% in the last year to ₹64.34 Cr. Its sector's average net profit growth for the last fiscal year was 25.86%.
notePrice to Earning Ratio,is 56.68, lower than its sector PE ratio of 60.22.
View more
Standard Glass Lining Technology Limited was incorporated as ‘Standard Glass Lining Technology Private Limited’ at Hyderabad, as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated September 6, 2012, issued by the Registrar of Companies, Andhra Pradesh. Subsequently, upon the conversion of the company into a public limited company, pursuant to a special resolution passed by its Shareholders on June 4, 2022, the name of the company was changed to ‘Standard Glass Lining Technology Limited’ and a fresh certificate of incorporation dated, June 17, 2022, was issued by the RoC. The company is one of the specialised engineering equipment manufacturers for pharmaceutical and chemical sectors in India, with in house capabilities across the entire value chain. Its capabilities include designing, engineering, manufacturing, assembly, installation and commissioning solutions as well as establishing standard operating procedures for pharmaceutical and chemical manufacturers on a turnkey basis. its portfolio comprises core equipments used in the manufacturing of pharmaceutical and chemical products, which can be categorized into: (i) Reaction Systems; (ii) Storage, Separation and Drying Systems; and (iii) Plant, Engineering and Services (including other ancillary parts).It possesses in-house capabilities to manufacture all the core specialised engineering equipment required in the active pharmaceutical ingredient (API) and fine chemical products manufacturing process. Its engineered solutions are used in processes across pharmaceutical, chemical, food and beverage, biotechnology and fertilizer sectors. It customises its products basis the unique process requirements of its customers. It also provided turnkey automated equipment solutions, optimising processes like vacuum distillation, solvent recovery and gas dispersion. It has a diversified customer base including end users operating in a range of sectors across pharmaceutical, chemicals, paint, bio technology and food and beverages.Business area of the companyThe company together with its subsidiaries is primarily engaged in the business of manufacturing and selling of glass lined reactors, receivers and storage tanks and is specialised in providing the turnkey solutions for the pharmaceutical industry sector.Products of the companyStorage tanksBe reactor (Batch Reactor)Roto cone vacuum dryerAe reactor (Anhydrous Ether Reactor)Heat exchangersAwards, accreditations and recognitions2015: Certificate of Equipment Performance for its glass lining surface by Laurus Labs Limited.2018: Certificate of Equipment Performance for its current goods manufacturing practices (CGMP), mild steel glass lined (MSGL) and stainless-steel glass lined (SSGL) reactors, receivers and condensors by Biocon Limited.2018: Certificate of Equipment Performance for its MSGL reactors and receivers by Dr. Reddy’s Laboratories Limited.2018: Certificate of Equipment Performance for its goods manufacturing process (GMP) CGMP and MSGL reactors] by Srini Pharmaceutical Private Limited.2018: The company received Certificate of Equipment Performance for its equipment GMP, CGMP, MSGL reactors, and receivers by Natco Pharma Limited.2019: Certificate of Equipment Performance for its equipment MSGL reactors and receivers by MSN Laboratories Private Limited.2019: Certificate of Equipment Performance for its equipment GMP, CGMP, MSGL reactors, receivers and storage tanks by Styrax Pharma Private Limited.2023: Global Management Certification Services Private Limited accredited the company with ISO 14001:2015 for design, manufacture and supply of glass lined equipment.2023: Global Management Certification Services Private Limited accredited the company with ISO 45001:2018 for design, manufacture and supply of glass lined equipment.2024: Global Management Certification Services Private Limited accredited the company with ISO 9001:2015 for design, manufacture and supply of glass lined equipment.2024: The National Board of Boiler Pressure Vessel Inspectors provided the company a certificate of authorization to use ‘R’ symbol.2024: The National Board of Boiler Pressure Vessel Inspectors provided the company a certificate of authorization to use ‘NB’ symbol.2024: The American Society of Mechanical Engineers provided the company a certificate of authorization to use ‘U’ symbol in relation to manufacture of pressure vessels in accordance with rules prescribed by ASME.History and milestones2013: Incorporated the Glass Lining Division.2014: Sold 100 glass lined reactors.2016: Supplied first unique stainless steel glass lined reactor to Natco Pharma Limited.2018: The Company hit a turnover of Rs 50 crore.2019: Finished construction of new facility of glass lining equipment at SGL Unit.2021: Its Material Subsidiary was incorporated as a wholly-owned subsidiary.2021: Its Material Subsidiary acquired metal business from M/s S2 Engineering Services and pumps business from M/s Stanpumps Engineering Industries.2022: Agreement with Climaveneta Climate Technologies Private Limited to enter the chillers market.2023: Investment from AGI Investors in the company.2024: Acquired Hyderabad based C.P.K. Engineers Private Limited.
personal

Grow your wealth with more research recommendations

+91